Chlorodehydromethyltestosterone (CDMT) (brand title Oral Turinabol) is an androgenic-anabolic steroid. It's the 4-chloro-substituted by-product of metandienone (dehydromethyltestosterone) (Dianabol). CDMT was the primary unique product of Jenapharm, an East German pharmaceutical firm. The patent registration passed off in 1961. The thought of mixing the constructions of 4-chlorotestosterone (clostebol) and metandienone originated from the chemist Albert Stachowiak. On the time this represented a novel dissociation of anabolic and androgenic results after oral administration. The product had been launched for clinical use in 1965.
It was the first original product of Jenapharm, an East German pharmaceutical company. The patent registration took place in 1961. At the time this represented a unique dissociation of anabolic and androgenic effects after oral administration. Turinabol quickly became the key steroid administered to approximately 10,000 athletes from East Germany (GDR). The doping program was run by the East German Government from about 1968 thru until 1989 when the Berlin wall was destroyed. The doping program was known as STASI . The doping was done in secret and it was only in the 1990s when Franke and Berendonk looked closely at the original archived information was the true scope of just how well-planned and successful the doping regime had been (in terms of medal success and world record performances).